NCT07581951: A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH
- State
- Under way
- Phase
- Phase 3
- People
- 886 planned
- Started
- 30 Jun 2026
- Primary completion
- 30 Jun 2029
- Arms
- HSK31679 dose
- Results
- None posted
- 12 May 2026: Trial registered
- 30 Jun 2026: Trial started